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ABSTRACT
The purpose of this study was to identify any needs patients with renal 
insufficiency living in a rural/frontier setting may have. A chart review was conducted in 
a rural health care facility of all patients with diagnostic code 593.9. The following 
questions were asked: What are the characteristics of the patients in this rural/frontier 
setting? What is the difference in their levels of renal insufficiency? What risk factors are 
related to the level of renal insufficiency? In what ways do their risk factors compare 
with those identified in literature? The results of this study were compared to what is 
stated in literature about the cause of renal insufficiency. After reviewing the data 
collected it was found that females were older, more likely to have congestive heart 
failure, and had higher glomelular filtration rates (GFR) than males at all four time 
periods. There was a significant decrease in systolic and diastolic blood pressure and 
GFR over time. The significant predictors of GFR at Time 1 were younger age, higher 
systolic blood pressure, lower diastolic blood pressure, and more miles from the clinic. 





Chronic Kidney disease affects more than 20 million Americans or one in nine 
adults, and most don’t know it. There are at least another 20 million people who are at 
“increased risk” for developing the disease (National Kidney Foundation, 2003). 
Americans have an above average chance of developing the disease due to the changing 
numbers in the ethnic and aging populations. The causes of kidney disease, or renal 
insufficiency, have been well documented: (1) diabetes; (2) high blood pressure 
(hypertension); (3) family history of chronic kidney disease; and (4) older age. It has also 
been documented that there is increased risk for renal failure in African Americans, 
Hispanics, Asian or Pacific Islanders and American Indians. Research by the National 
Kidney Foundation (2002) has determined that 40% of kidney disease is caused by 
diabetes, 30% by hypertension, and 30% by other causes.
This study explored the prevalence of renal insufficiency in a small rural area of 
northeastern North Dakota. The population of the study community is 1400. The U.S. 
Bureau of Census defines rural as a population of 2500 or less. The facility in this study, 
though small, serves several outlying communities (within a 60 mile radius) whose 
population is much less.
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Significance of the Study
It is unclear whether patients in rural areas are seeking and receiving the care that 
they need and how these patients compare to urban populations in regard to the risks for 
renal insufficiency. Diabetes is the only risk factor for renal insufficiency that has been 
studied in North Dakota. This study addressed the role of previously documented factors 
and how they relate to renal insufficiency. Once these data are evaluated and compared 
with results from national studies, one can identify the next steps toward determining 
possible educational needs of rural-dwelling patients diagnosed with renal insufficiency.
Purpose of the Study
The purpose of this study was to identify characteristics of persons with the 
diagnosis of renal insufficiency who live in a rural/frontier setting.
Conceptual/Theoretical Framework
A physiological framework of renal insufficiency was used for this study. Renal 
insufficiency and kidney failure are used interchangeably. Kidney failure is characterized 
by the failure of the kidney to remove all waste products. According to Dudley (2003), 
when kidney function decreases, there is a build up of waste products in the blood. If the 
build up is mild, no symptoms appear. If the failure continues, symptoms appear; this 
may take weeks or years. Renal failure is considered either acute or chronic. Acute renal 
failure occurs over days, week, and months, while chronic renal failure occurs slowly 
over years. People with uncontrolled hypertension and diabetes have been found to be at 
risk for developing kidney disease. Family history of diabetes and or hypertension is 
considered a risk for developing renal insufficiency. These concepts are more fully 




The topics covered in the literature review are those that comprise the conceptual 
framework: physiologic factors that affect the kidney, leading to the renal insufficiency, 
and the factors related to renal insufficiency.
Defining Renal Insufficiency
To define renal insufficiency, the literature was reviewed for physiological 
aspects. Hansen (1998) explained that the urinary system is divided into the upper urinary 
tract, consisting of the kidneys, and the lower urinary tract consisting of the ureters, 
bladder, and urethra.
Inside each kidney there are 1 million nephrons. Each nephron has a glomerulus, 
capillaries and tubules. It is known as the functional unit of the kidney. It is damage to 
this functional unit (nephropathy) that determines the level of renal insufficiency 
(Hanson, 1998).
Each day the kidneys process about 200 quarts of blood. Of this, two quarts are 
filtered out as waste and extra water; this becomes urine. It is the glomerulus that does 
the filtering; each glomerulus is connected to a tubule which receives waste and 
chemicals, returning what can be used back to the body and sending the rest to the 
bladder as waste. The kidneys return sodium, potassium, glucose, bicarbonate and 
phosphorous back into the blood so it can return to the body. The kidneys also have
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another function: they release three hormones to assist in continued whole body 
homeostasis. The hormones released are: (1) erythropoietin (EPO) which stimulates bone 
marrow to make red blood cells; (2) rennin , which regulates blood pressure; and 
(3) vitamin D, which helps maintain calcium balance.
Manifestations of Renal Insufficiency
The symptoms associated with the renal insufficiency may be insidious. The 
symptoms of renal insufficiency are as follows; fatigue with decreased mental 
acuity, muscle cramps or twitching, anorexia, nausea, vomiting, and or an 
unpleasant taste in the patient’s mouth, and finally the patient’s skin may appear 
yellow or gray secondary to retention of urinary pigments. (Hanson, 1998, p. 540) 
These patients may also experience anemia, acidosis, and lipid abnormalities as 
well as malnutrition. The malnutrition and anemia are due to the restriction of protein. 
The importance of diet cannot be expressed enough in some cases. Diet needs to be 
modified to reduce the intake of protein, sodium, potassium, fluids, and phosphate. There 
should be an addition of a water soluble multivitamin supplement to replace vitamins lost 
(Sloan, 2002).
The fatigue the patient feels is most likely due to the depletion of iron stores due 
to the decreased hormone erythropoietin production by the kidneys. This should be 
closely monitored, and anemia treated only when the Hematocrit falls below 18. Fatigue 
was the biggest and most frequently expressed complaint by patients. Anemia becomes 
more of a factor in chronic renal insufficiency due to shortened red blood cell survival 
with patients receiving hemodialysis; in these cases, Epoetin is given. Studies show, 
however, that this should be started long before the patient is in chronic failure 
(Onyekachi et al., 2001).
The diagnosis of renal insufficiency is made by monitoring of several lab values.
These lab values can be monitored if a complete blood panel is done. The following labs
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are monitored: Serum creatinine is a product of muscle metabolism; a rise in this value 
indicates a decrease in kidney function. Blood urea nitrogen (BUN) is a reflection of 
renal excretion of urea which is a product of protein metabolism. BUN may begin to rise 
with decrease in glomerular filtration rate. Urine creatinine measures the amount of 
creatinine excreted in the urine. Hematocrit and hemoglobin are both affected by the 
release of the hormone erythropoietin (EPO) from the kidney. Erythropoietin affects the 
body’s ability to produce the red blood cells which carry oxygen to the rest of circulatory 
system. Potassium is a mineral which is freely filtered by the glomerulus; it is responsible 
for the resting membrane potential in muscle and cardiac cells. An increase or decrease in 
potassium level can cause irregular heart rhythm. Blood pressure is partially regulated by 
the hormone renin, which is synthesized by the kidney. In the blood stream, renin 
activates the protein angiotensin I. Angiotensin I circulates through the body and is 
converted to angiotensin II by angiotensin converting enzyme (ACE) in the lungs. 
Angiotensin II increases vasoconstriction and therefore reduces renal blood flow. 
Angiotensin II also stimulates the adrenal cortex to release aldosterone which promotes 
sodium and water reabsorption and ultimately blood pressure increases (Hansen, 1999). 
To prevent kidney damage, blood pressure needs to be maintained at a safe level between 
systolic 120-139 mmHg and diastolic 80-89 mmHg. as per The Seventh Report of the 
Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High 
Blood Pressure (JNC 7).
The glomelular filtration rate (GFR) indicates renal function. The measurement is 
done by using blood creatinine, age, ideal body weight, and gender. The GFR helps to 
determine the stage of renal insufficiency. The following numbers are entered into what 
is called the Cockroft-Gault equation (140-age) X (ideal body weight, IBW) divided by 
creatinine x 72 x (0.85 if female) = creatinine clearance (McCullough, 2003).
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The creatinine clearance reflects the GFR and gives an indication of the adequacy 
of kidney function. To perform this measurement, a 24 hour urine is collected and at 
midpoint of this collection a plasma creatinine is obtained. The following formula is 
used: Ccr=TJcr (urine creatinine) x Uv (urine volume/per time) divided by Per (plasma 
creatinine) (Preisig et al., 1998).
The stages of kidney disease are:
• In Stage 1, there is kidney damage but a normal GFR(> 90 ml/min.);
• In Stage 2, there is kidney damage and a mild decrease in GFR (60-89 
ml/min.);
• In Stage 3, there is a moderate decrease in GFR;
• (30-59 ml/min.);
• In Stage 4, there is a severe decrease in GFR (15-29 ml/min.);
• In Stage 5, kidney failure GFR (< 15 ml/min.).
To determine who is at risk for kidney disease, there is a short self test which any 
one over the age of 18 can take. It is called the Kidney Early Evaluation Program (KEEP) 
test. The test consists of five simple questions: (1) Do you have high blood pressure?
(2) Do you have diabetes? (3) Do you have a parent, grandparent, brother or sister with 
high blood pressure? (4) Do you have a parent, grandparent, brother or sister with 
diabetes? (5) Do you have a parent, grandparent, brother, or sister with chronic kidney 
failure? A yes answer to any of these questions places one at risk for kidney disease 
(National Kidney Foundation, 2004).
Research Studies
The following studies show that the most frequent factors found to be related to
renal disease are diabetes, hypertension, and/or family history of renal insufficiency.
Fadem (1999) conducted a 2-year longitudinal study (1997-1999) for the Nephron
Information Center. The findings revealed that approximately 16 million Americans have
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diabetes and, of those, 10 million have early renal insufficiency. The data also revealed 
that, in the 10 years prior to 1999, the incidence of diabetes induced renal insufficiency 
rose sharply. As a result of this study, published guidelines were developed for early 
interventions in diabetic patients with renal insufficiency. The author suggested that the 
patient provider should start working with the patient when the serum creatinine is 
greater than 1.5mg/dl (women) and 2.0mg/dl (men) and when the urine 
albumin/creatinine ratio is > 30.
Young et al. (2002) conducted a study which addressed systolic hypertension in 
older adults. The study looked at the relationship between baseline blood pressure and the 
incidence of decline in kidney function. The decline in kidney function is defined as an 
increase in serum creatinine equal to or greater than 0.4mg/dl over a five year follow up 
(Young et al., 2002 p. 2776 ). The study began by recruiting 4736 men and women over 
the age of 65. Participants with creatinine levels >2.0mg/dl were excluded, leaving 4425 
participants. To determine the risk of decline in kidney function associated with blood 
pressure in older men and women, 2181 participants were selected for the randomized 
placebo group. Participants were evaluated by doing four sets of blood pressures; an 
average was then used for baseline. Exclusion criteria included anyone with past history 
of myocardial infarction, stroke, cancer, alcoholic liver disease, insulin dependent 
diabetes, depression and kidney failure. Serum creatinine levels were then assessed. A 
baseline serum creatinine was established and a yearly outcome of 0.4mg/dl was chosen 
as a point of significance. Patients who were currently taking anti-hypertensive drugs 
stopped these medications for two weeks before their serum creatinine levels were 
assessed; if their level was 2.0 mg/dl, they were excluded. It was concluded that 
participants with higher systolic blood pressure tended to be older, were more often 
women, and had lower diastolic blood pressures .This study also concluded that systolic
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blood pressure is a strong independent risk factor for the decline in kidney function 
(Young et al., 2002).
Mann et al. (2001) reported the results of the HOPE (Heart Outcomes and 
Prevention Evaluation) study. This was a randomized, double blind study involving 980 
patients with renal insufficiency and 8,307 patients with normal renal function. The 
primary purpose of the study was to measure the incidence of cardiovascular death, 
myocardial infarction, and/or stroke in clients with renal insufficiency. The study 
included men and women over the age of 55 who had at least one cardiovascular disease. 
In addition, a serum creatinine of at least 1.4mg/dl identified which patients had renal 
insufficiency. This study concluded that if patients had a vascular disease or diabetes 
combined with another cardiovascular risk factor and mild renal insufficiency, they were 
at twice the risk of more cardiovascular events and or mortality. The authors further 
concluded that even mild renal insufficiency should be seriously considered as a 
cardiovascular risk factor. They noted that Angiotensin-converting enzyme (ACE) 
inhibitors decreased the risk of cardiovascular disease in patients with renal insufficiency 
and should not be discontinued because there may be an increase in serum creatinine 
(Mann et al., 2001).
Mann et al. (2000) also studied the effects of ACE inhibitors and progression of
renal insufficiency. When ACE inhibitors were used in trials with animals, there was a
significant slowing of the progression of renal insufficiency. Men and women were
recruited between the ages of 18 and 70, with creatinine levels 1.5-4.0 mg/dl. During this
trial, blood pressure was treated to maintain diastolic levels less than 90 mm/hg. Insulin
dependent diabetics were excluded. The sample consisted of a drug group and a placebo
group. Several subjects dropped out of the study for various reasons and there was a
higher mortality rate among the drug group. It was concluded that more study needs to be
done with ACE inhibitors in patients with renal insufficiency. Mann suggested that
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perhaps this classification of drug was harmful to participants who had renal problems. 
They stated that:
cumulative incidence of primary outcome (myocardial infarction, cardiovascular
death and all death for patients with a serum creatinine concentration less than 1.4
mg/dl or at least 1.4 mg/dl) was higher in patients with renal insufficiency than in
those without. Patients with renal insufficiency had a substantially increased risk
for cardiovascular death and increased total mortality rate. The ACE inhibitor,
Ramipril, reduced the incidence of primary outcomes in patients with and those
without renal insufficiency. Mortality and heart failure was greater in patients
with renal insufficiency than those without. (Mann et al., 2001, p.4)
A study conducted in Japan used a meta-analysis to study the effect of ACE -
inhibitors on outcomes in patients with renal insufficiency. This analysis compared 15
other studies that had been conducted on the use of ACE inhibitors. All 15 studies
concluded that: “ace-inhibitors are effective in controlling the progression of renal
disease not only in patients with elevated serum creatinine above 3.0mg/dl but also in
patients with serum creatinine below 3.0mg/dl. Future research will be conducted to
clarify the risks and benefits” Terajima, 2003).
The following findings were reported by Knobler (2004) from a study of the
reduction in glomelular filtration rate in diabetic patients. Seventy seven patients had a
reduced GFR < 60ml/min compared to 177 patient with GFR >60ml/min; the reduced
GFR group was older and had a longer duration of diabetes and a significant two-fold
increase in cardiac events. The study concluded that a reduced GFR was common in
asymptomatic diabetic patients. The results of the multivariate analysis showed the
reduced GFR to be the independent variable that predicts cardiac events.
The Prospective Cohort Study of Chronic Renal Insufficiency (CRIC) is currently
in progress. It is a longitudinal cohort study of 300 persons ages 21 to 74 with mild to
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moderate chronic renal insufficiency. The cohort is racially and ethnically diverse (40% 
white, 40% African American, and 20% other), and approximately half of the participants 
have a diagnosis of diabetes mellitus. This is a seven year study to develop a perspective 
of the racial, ethnic and gender composition of persons with End Stage Renal Disease 
(ESRD). This study also makes a statement about previous and current studies: “all have 
had important shortcomings, small sample size, short term follow up, use of select 
populations, lack of ethnic and racial diversity, low rate of female participants, limited 
assessment of potential risk factors, and inclusion of select causes of renal disease” 
Feldman (2003).
Research Questions
The following questions were addressed in the current study:
1. What are the characteristics of adults in a rural/ffontier area with renal





Health care use (clinic visits and hospitalizations)
Support systems
2. What differences are there in the levels of renal insufficiency?
3. What risk factors are related to the level of renal insufficiency?
4. In what ways do their risk factors compare with those identified in the 
literature?
Definitions
Rural/frontier. population density of this area served ranges anywhere from 3.2 to
9.7 persons per square mile as stated by North Dakota Bureau of Census.
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Renal Insufficiency: is determined by the glomelular filtration rate 
(GFR). The stages are defined on page six.
Demographics'.
Distance from clinic', the miles the participants have to travel from their home to 
health care center.
Age: year they are in life cycle
Sex: male or female
Co-morbidities: include other diseases such as: diabetes; hypertension; congestive 
heart failure (CHF); and coronary artery disease (CAD).
Medications: medications for diabetes and/or hypertension since these are the 
primary cause of renal insufficiency.
Lab values: there are many that are monitored and these are listed in the literature. 
Values reflecting the frequency and progression of disease as listed on pages five and six 
were included in this study.
Support system: the status of family members, whether they lived alone and who 
served as primary care givers.





This chapter will explain the design of this study and the variables which were 
looked at for this study. The study design is that of a chart review of patients with the 
diagnostic code 593.9 in a rural health care facility. The chart review examined several 
variables: age, sex, diagnosis, frequency of exams, lab values, medications, distance from 
the facility, and social support. The study site was a 14 bed Critical Access Hospital and a 
Rural Health Clinic which has two Family Practice Physicians, and one Physician 
Assistant. There was also a doctor’s clinic which employs one part time surgeon.
Population and Sample
The population was all patients with the diagnosis of renal insufficiency within 60 
miles of study facility who had been hospitalized or treated in this small rural 
hospital/clinic setting during a one year period. The areas where these patients live are all 
highly rural and the area is considered low income. The patients included for this study 
had the diagnosis of renal insufficiency, which is identified by the International 
Classification of Diseases 593.9. The data were collected for four times over a one year 
period for more accurate comparison and validity. The following measures were 
collected: 1. Age, 2. Sex, 3. Diabetes or history of, 4. Hgb. Ale, 5. Medications for 
diabetes, 6. Hypertension or history of, 7. Blood pressure medications, 8. Anemia, 9.
GFR, 10. BUN, 11. Serum Creatinine, 12. Hgb., 13. Hct. 14. Other co-morbidities, 15.
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Distance from the clinic/hospital, 16. A positive family history for diabetes, 
hypertension, and renal problems or insufficiency. All charts with complete date were 
included resulting in a sample size of 85. In one case only one value required for 
calculation of the GFR was missing for Time 2 and Time 3. This case was not included, 
in data analysis related to the GFR for those time periods. Random numbers were 
assigned to medical record numbers to protect privacy.
Human Subjects
Prior to data collection, permission for this study was granted by the Institutional 
Review Board (IRB) at the University of North Dakota and the facility administration, 
with the assurance that the patient’s privacy would be protected according to HIPPA 
guidelines with oversight of the facility health information director. The data collection 
form is presented in Appendix A. Random numbers were assigned to medical record 
numbers to protect privacy. The number was used by the reviewer for reference. 
Permission from IRB was sought and given under the condition that the data would be 
kept in a double locked system with the only access by this researcher and the head of 
Health Information Services in the facility in which the data was collected. These records 
will remain locked for a three year period and then destroyed. As stated earlier, each 
chart number was given a dummy number to be used only by the researcher if needed to 
recheck any data. No names or other information which could identify the patient or their 
chart were collected.
Statistical Analysis
The first research question asked about the characteristics of rural/frontier adults
with renal insufficiency. It was addressed using descriptive statistics, frequencies, and
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cross-tabulations by gender. To answer the second research question, involving changes 
in the level of renal insufficiency, mean levels of renal insufficiency as measured by the 
GFR were plotted at four points over the year. This was done by using the four visits for 
health care over a one year period. The third research question asked what risk factors are 
related to renal insufficiency. A multiple regression analysis was used to answer this 
question. The dependent variable was the GFR at time one. The independent variables, or 
predictors, were: age, ACE inhibitor, systolic B/P, diastolic B/P, number of miles from 
the clinic, diabetes, and family history of hypertension and diabetes. These variables 
were measured as dichotomous (0= no, 1= yes) variables. Creatinine level and sex were 
not included as independent variables because they are involved in calculation of the 
GFR. The analysis looked at the beta values, each of which shows the degree of change 
in the dependent variable (GFR) with all of the other independent variables kept constant. 
To answer the fourth research question, results from major studies of risk factors related 




The purpose of this study was to identify possible needs of persons with the 
diagnosis of renal insufficiency in a rural frontier area. To achieve this, a chart review 
was conducted in a small rural healthcare facility in northeastern North Dakota. The data 
collection instrument included not only demographic information but information that 
would answer the four research questions as they refer to persons in a rural/ffontier area 
with the diagnosis of renal insufficiency. The time period over which data were collected 
was four visits over one year.
Research Question Number One: What are the characteristics o f adults in a rural/ 
frontier area with renal insufficiency in relation to: Demographics, Co-morbidities, 
Medications, Lab Values, Health Care Use and Support Systems? Tables 1 through 7 
show frequencies and percentages that compare males and females by age groups, 
diagnosis, family history of disease, distance from clinic, systolic and diastolic blood 
pressures at times one and GFR at all four times for the total sample. There were only 
four patients who did not have any type of support system (percentages may total greater 
than 100% due to rounding).
The number of males versus females in this study was almost equal with 42 males 
and 43 females. Males dominated the 70-79 year age group (35.7%) and females 
dominated the 80-89 year age group (53.5%). The predominant diagnosis was
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hypertension (41.2%). A larger percent of the females than the males had hypertension 
(46.5% females versus 35.7% males), although the reverse was true for a diagnosis of 
diabetes. Nearly a quarter (23.3%) of the females had a diagnosis of CHF, while a larger 
percent of the males had CAD (19.6%).








35-39 Years 3 7.1 0 3 3.5
60-69 Years 4 9.5 4 9.3 8 9.4
70-79 Years 15 35.7 8 18.6 23 27.1
80-89 Years 13 31.0 23 53.5 36 42.4
90 + Years 7 16.7 8 18.6 15 17.6
Total 42 100 43 100 85 100
Table 2. Diagnosis of Disease.
Male Female Total
Diagnosis # % # % # %
Hypertension 15 35.7 20 46.5 35 41.2
Diabetes 5 11.9 7 16.3 12 14.1
Hypertension./Diabetes 8 19.0 3 7.0 11 12.9
CHF 4 9.5 10 23.3 14 16.5
CAD 8 19.0 3 7.0 11 12.9
Cancer 2 4.8 0 0 2 2.4
Total 42 49.4 43 50.6 85 100
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Hypertension 24 58.5 18 41.9 42 50.0
Diabetes 6 14.6 10 23.3 16 19.0
Hypertension./Diabetes 4 9.8 6 14.0 10 11.9
Renal Problems 4 9.8 7 16.3 11 13.1
Renal /Hypertension. 2 4.9 2 4.7 4 4.8
Renal/Diabetes 2 2.4 0 0 2 1.2
Total 42 48.8 43 51.2 85 100
Family history of disease also varied between males and females. Males were
more likely to have a family history of hypertension and females one of diabetes.
More than half of the patients lived within 10 miles of clinic. Males were more
likely than females to live; more than 10 miles from the clinic (50.4% versus 44.1%).
Table 4. Distance From Clinic.
Miles from Male Female Total
Diagnosis # % # % # %
1-10 Miles 21 50.1 24 55.8 45 52.9
11-20 Miles 7 16.8 10 23.2 17 20.0
21-30 Miles 6 14.4 4 9.3 10 11.8
31-40 Miles 4 9.6 1 2.3 5 5.9
41-55 Miles 4 9.6 4 9.3 8 9.4
Total 42 100% 43 100% 85 100
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Systolic and diastolic blood pressure at Time 1 were examined (see Tables 5 and 
6). A larger percentage of females (76.8%versus 66.7% for males) had a systolic blood 
pressure exceeding 120mm/Hg., but males had a higher percentage (39.4% versus 24.3% 
for females) with a diastolic blood pressure of 80mm/Hg or more.
Table 5. Systolic Blood Pressure at Time 1.
Systolic Blood Male Female Total
Pressure x 1 # % # % # %
90-120 mm Hg 14 33.3 10 23.3 24 28.2
121-139 mm Hg 13 31.0 14 32.6 27 31.8
140 + mm Hg 15 35.7 19 44.2 34 40
Total 42 100 43 100 85 100
Table 6. Diastolic Blood Pressure at Time 1.
Diastolic Blood Male Female Total
Pressure # % # % # %
60-69 mm Hg 8 24.2 13 35.1 21 30.0
70-79 mm Hg 12 36.4 15 40.5 27 38.6
80-89 mm Hg 13 39.4% 9 24.3% 22 31.4%
Total 33 47.1% 37 52.9% 70 100%
Table 7 shows male and female differences in GFR at all four times. At all times 
the females had higher GFR’s. At all times, higher percentage of females than males 
were at stages 3 and 4 of renal insufficiency.
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Table 7. Glomelular Filtration Rate at Times 1-4 by Sex.
G F R  x  1 #
M a le
% #
F e m a le
% #
T o ta l
%
> 9 0  m l./m in 14 33.3 5 11.6 19 22 .4
6 0 -8 9 m l./m in 15 35 .7 10 23.3 25 29 .4
3 0 -5 9  m l./m in 11 26 .2 22 51 .2 33 38 .8
15-29 m l./m in . 2 4 .8 6 14.0 8 9 .4
T ota l 42 100 43 100 85 100
M ale F em ale T ota l
G F R  x  2 # % # % # %
> 9 0  m l./m in . 11 26 .8 6 14.0 17 20 .2
6 0 -8 9  m l./m in . 13 31 .7 5 11.6 18 21 .4
3 0 -5 9  m l./m in . 14 34.1 24 55 .8 38 45 .2
15-29 m l./m in . 3 7.3 8 18.6 11 13.1
T otal 41 100 43 100 84 100
M ale F em ale T ota l
G F R  x  3 # % # % # %
> 9 0 m l./m in . 10 24 .4 4 9.3 14 16.7
6 0 -8 9  m l./m in . 14 34.1 12 27 .9 26 31 .0
3 0 -5 9  m l./m in . 13 31 .7 16 37 .2 29 34 .5
15-29 m l./m in . 4 9.8 11 2 5 .6 15 17.9
T ota l 41 100 4 2 100 84 100
M ale F em ale T ota l
G F R  x  4 # % # % # %
> 9 0  m l./m in . 10 23 .8 4 9.3 14 16.5
6 0 -8 9  m l./m in . 11 26 .2 9 20 .9 20 23.5
3 0 -5 9  m l./m in . 13 31 .0 20 46 .5 33 38 .8
15-29m l./m in . 8 19.0 10 23.3 18 21 .2
T ota l 42 100 43 100 85 100
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Research Question Number Two: What are the differences in levels o f renal 
insufficiency? The Friedman analysis of variance by ranks tested the difference across 
time in systolic and diastolic blood pressure and GFR clearly answers this question. The 
Friedman analysis of variance by ranks is the non -parametric equivalent of the within 
subjects repeated measures ANOVA. The independent variable was time, which has four 
levels. The dependent variables are the systolic blood pressure and diastolic blood 
pressure and GFR. The results of the Friedman are shown in tables 8, 9, and 10. The 
Friedman Test results show statistically significant decreases in the systolic and diastolic 
blood pressure and the GFR from Time .One to Time Four. The largest decrease appears 
between Time 2 and Time 3 for blood pressures and between Time 3 and Time 4 for the
GFR.
Table 8. Systolic Blood Pressure at Times 1-4, Friedman Test (N=85).
Time Mean Mean Rank Chi-Square Significance
Time 1 134.059 2.66 17.688 .001
Time 2 138.577 2.89
Time 3 131.576 2.27
Time 4 129.870 2.18
Table 9. Diastolic Blood Pressure at Times 1-4, Friedman Test (N=85).
Time Mean Mean Rank Chi-Square Significance
Time 1 71.177 2.54 13.474 .004
Time 2 72.823 2.89
Time 3 69.705 2.28
Time 4 68.7529 2.28
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Table 10. Glomelular Filtration Rate at Times 1-4, Friedman Test.
Time Mean Mean Rank Chi-Square Significance
GFR 1 71.414 2.97 20.974 .000
GFR 2 67.119 2.52
GFR 3 65.292 2.42
GFR 4 62.013 2.08
Research Question Number Three: What risk factors are related to the level o f 
renal insufficiency? This question was addressed with a multiple regression analysis; 
dummy variables were created for diabetes, family history of diabetes, and family history 
of hypertension. Because systolic and diastolic blood pressure at Time 1 were included, a 
diagnosis of hypertension was not included. Calculations for the creation of the dummy 
variables are shown in Table 11. Results of the Multiple Regression are listed in Table 
12.
The significant predictors of GFR Time 1 were: younger age, higher systolic 
blood pressure, lower diastolic blood pressure and more miles from the clinic. Use of 
ACE inhibitors, diagnosis of diabetes, and family history of diabetes or hypertension 
were not significant predictors. The equation yielded an R Square of .377, meaning that 
over 37% of the variance in the GFR was explained by this combination of variables.
The F ratio was statistically significant. A similar analysis was conducted 
with GFR at Time 4 as the dependent variable and including GFR at Time 1 as a 
predictor. The only significant predictor of GFR Time 4 was GFR Time 1.
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Table 11. Dummy Variables for Diabetes, Family History of Diabetes/Hypertension.
Original Variable If Target Variable Equals




Family History 1 Family History Hypertension 1
Hypertension 2 Family History Hypertension 0
3 Family History Hypertension 1
4-6 Family History Hypertension 0
Family History Diabetes 1 Family History Diabetes 0
2 Family History Diabetes 1
3 Family History Diabetes 1
4-6 Family History Diabetes 0
Table 12. Predictors of GFR at Time 1: Multiple Regression
Predictor Beta Sig. F Sig. ofF
Age -.499 .000 5.674 .000
Ace Inhibitor -.131 .168
Systolic B/P T1 .257 .026
Diastolic B/P T1 -.213 .056
Number of Miles From Clinic .191 .050
Diabetes -.037 .756
Family Hx. Diabets -.065 .605
Family Hx.Hypertension. .163 .111
R Square = .377
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Research Question Number Four: In what way do the risk factors compare with 
those identified in literature? The following table compares the risks of participants in 
this study versus those found in literature. There are no tables available in the literature 
that depict percentages of risk factors.





Source of Data : National Kidney Foundation, 2004
Thus, this study showed a much greater percentage of participants with 
hypertension and a much lower percentage of participants with diabetes than stated 




The purpose of this study was to assess the needs of patients diagnosed with renal 
insufficiency living in a rural/frontier setting. A chart review of all patients with 593.9 
diagnostic code (renal insufficiency) was conducted. The sample size was 85 (42 males 
and 43 females).
Conclusions and Discussion
The first research question asked about the characteristics of the sample. 
Percentages of males and females were compared in regard to age, distance from the 
clinic or access to health care, support system, medications and co-morbidities. The 
co-morbidities examined in this study were hypertension, diabetes, congestive heart 
failure (CHF), coronary artery disease (CAD), and cancer. The patients ranged in age 
from 35 to 90 plus years. The largest age group for men was the 70-79 year age group 
and for the women the 80-89 year age group. The 80-89 year age group was the largest 
with a total of 36 patients.
Hypertension was the predominant disease diagnosis (35.7% of the males, and 
46.5% of the females). Diabetes as well as a diagnosis of both diabetes/hypertension were 
second and third, 11.9% males and 16.3% females and 19.0% males and 7.0% females, 
respectively. The other co-morbidities (CHF, CAD, and Cancer) were present in 27 
patients. The most prominent of these was CHF (9.5% of males and 23.3% of females).
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Examination of the data found that only 23 of the participants were taking an ACE 
inhibitor. The literature states that the use of an ACE inhibitor for hypertension with renal 
insufficiency reduces cardiac risks. An article by Reis (2002) stated that mild renal 
insufficiency may be an independent predictor of atherosclerotic coronary heart disease 
(CAD) in women; women with mild renal insufficiency were times more likely to have 
significant CAD than those with normal renal function. One could only speculate that the 
lack of ACE inhibitor use could be considered a contributing factor to the high incidence 
of CHF among the women in this study.
The distance from the clinic was a statistically significant predictor of Time 1 
GFR. Over half of the patients lived within 10 miles of available health care. There was a 
greater percentage of females than males living more than 10 miles from clinic. This 
could be important because these patients tended to be in their 70’s and 80’s and possibly 
dependent on family for transportation. This is often the case in rural areas.
The hypertension risk factors according to Seventh Report of the Joint National 
Committee on Prevention, Detection, Evaluation (JNC7) are: normal blood pressure 
<120/<80mmHg, pre-hypertension 120-139/80-89, and hypertension >140/>90. The 
systolic blood pressure results at Time 1 revealed 31.0% of male and 32.6% of female 
patients were in the pre-hypertension category and 35.7% of males and 44.2%of females 
were in the hypertension category. The diastolic blood pressure results at time 1 revealed 
36.4% of males and 40.5% of females at the pre-hypertension stage and 39.4% of males 
and 24.3% of females at the hypertension stage. These results suggest that the systolic 
blood pressure, not the diastolic, may be the greater concern. This is contrary to what has
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been our current position on the importance of elevations in systolic versus diastolic 
pressures in hypertension. All patients had an initial blood pressure check, but not all 
patients had their blood pressure checked on subsequent visits. Charts lacking the data 
available to calculate the GFR for at least two times in a one year period were excluded. 
All charts with complete data were included making up our sample size of 85.
Family history of disease, especially diabetes and hypertension, the two main 
predictors of renal insufficiency, were studied along with the history of renal problems. 
The family history of hypertension amongst men was 28.2% compared to 21.2% for 
women. The history of diabetes was much less for men (14.6%) than for women (23.3%). 
There were more patients with the actual diagnosis of diabetes and hypertension than 
their family history shows. Family history of disease was not a significant predictor of the 
GFR at Time 1, although the literature states it is an important risk factor. It is unclear 
from this study how much attention in assessments is given to family history of disease. 
Reasons for this inconsistency may be related to the chart review as family history may 
have not been always recorded or recorded accurately.
The main lab values examined were the BUN and Serum Creatinine; these were 
used along with the age, weight, and sex to determine the level of kidney function. This is 
expressed as the Glomelular Filtration Rate (GFR). At Time 1, 38.8% of patients were at 
stage 3; this increased to 45.2% at Time 2, then decreased to 34.5% at Time 3 and 38.% 
at Time 4. There was a slow increase in the percent at stage 4 across the four time 
periods. The GFR of patients at the other times were constant at a range of 35% to 38%.
A greater percent of males, than females were at mild and stage two or higher stages 
across all four time
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periods. These results may reflect better monitoring of medications and other factors after 
the medical diagnosis was made. They also may reflect the younger age of the men.
There is nothing in the data that would indicate why the changes occurred at these times. 
It may have occurred with a change or addition of medications, or the first time treatment 
was sought. Literature states that a decrease GFR is a predictor of cardiac events. It is 
paramount that the GFR be monitored closely over time.
A comparison of the study results regarding risk factors with the percentage listed 
in the literature yielded a major discrepancy. The literature states that 40% of those with 
renal insufficiency had diabetes and 30% had hypertension (National Kidney Foundation, 
2003). The study results indicate that 57.5% of the patients had hypertension and only 
28.5% had diabetes (excluding those with both diagnoses). One could only speculate why 
this discrepancy occurred. A possible reason is lack of education about hypertension. 
Little patient education is conducted with the newly diagnosed hypertension patient, as 
compared to the newly diagnosed diabetic who undergoes many hours of education. 
Another reason for the discrepancy may be related to the change in the diagnostic criteria 
for hypertension. Lowering of these normal values may increase the number of patients 
diagnosed with hypertension.
Study Limitations
The main limitation to this study is the chart review design, which limited the 
sample size. The numbers of patients were definitely available, but the data to support 
their illness was not. It was difficult to conduct a multiple regression, as the number of 
predictors that could be used in a multiple regression was limited. The limitations in the
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design are thus congruent with those in many of the other previous studies. They tended 
to be small with limited data.
Recommendations for Further Study
More study needs to be done in the area of prescribing an ACE inhibitor, or at 
least the reasoning why one is not being used, or if it has been used and failed. No data 
were collected in this study regarding other types of blood pressure management being 
used in the rural area. There were no data collected in regard to the number of patients 
who actually had a 24 hour urine study. This should be investigated if a similar study is 
conducted. If a 24 hour urine is ordered and not completed, perhaps compliance is a 
factor.
It would be interesting to interview each of the patients with 593.9 diagnostic 
code to see what they actually know about their renal insufficiency and its causes. 
Questions should address whether they have hypertension and what they know about 
their disease. The data collected from these interviews could then be used to develop an 
educational tool for patients and their families as well as a tool for the professional to 
teach patients about their high blood pressure and the risks which are present.
Recommendations for Practice
This study has definitely yielded greater awareness of the incidence of 
hypertension and educational needs that need to be met. Providers need to be more 
aggressive with their patients in the area of hypertension as well as providing more 
educational opportunities for the communities that they serve. An educational tool that 
will help patients in the rural setting become more aware and possibly better informed
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about their disease needs to be developed. A greater emphasis also needs to be placed on 
provider awareness of family history of disease, particularly hypertension.
A lot of emphasis in literature and in practice appears to focus more on the 
diagnosis of diabetes and patient education. This study results suggest that there may be a 
shift more in the direction of hypertension and cardiac disease, though there may or may 
not be some areas where diabetes is the prevalent diagnosis among patients with renal 
insufficiency.
Summary
This research study began due to the increased numbers of patients being seen 
with a common diagnosis of renal insufficiency. It set out to discover why this increase 
occurred in this rural area. The study sample and design varied only slightly from what is 
stated in literature. For example, it was small, lacked ethnic and racial diversity and only 
had a limited assessment of risk factors, which compares quite well to a statement made 
in a report on the CRIC Study (Kusek, 2003). An unexpected result was the important 
role of elevated systolic blood pressure as a predictor of renal insufficiency. This result is 
contrary to what has been taught in the past about hypertension. The higher percentage of 
patients with hypertension versus diabetes was also amazing. It will be interesting to see 
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